スポンサーリンク

Breast Cancer Institute, Fudan University Cancer Hospital | 論文

• Combined effects of lapatinib and bortezomib in human epidermal receptor 2 (HER2)-overexpressing breast cancer cells and activity of bortezomib against lapatinib-resistant breast cancer cells

スポンサーリンク